Literature DB >> 20724603

The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Mariya T Sweetwyne1, Manuel A Pallero, Ailing Lu, Lauren Van Duyn Graham, Joanne E Murphy-Ullrich.   

Abstract

Amino acids 17-35 of the thrombospondin1 (TSP1) N-terminal domain (NTD) bind cell surface calreticulin to signal focal adhesion disassembly, cell migration, and anoikis resistance in vitro. However, the in vivo relevance of this signaling pathway has not been previously determined. We engineered local in vivo expression of the TSP1 calreticulin-binding sequence to determine the role of TSP1 in tissue remodeling. Surgical sponges impregnated with a plasmid encoding the secreted calreticulin-binding sequence [NTD (1-35)-EGFP] or a control sequence [mod NTD (1-35)-EGFP] tagged with enhanced green fluorescent protein were implanted subcutaneously in mice. Sponges expressing NTD (1-35)-EFGP formed a highly organized capsule despite no differences in cellular composition, suggesting stimulation of collagen deposition by the calreticulin-binding sequence of TSP1. TSP1, recombinant NTD, or a peptide of the TSP1 calreticulin-binding sequence (hep I) increased both collagen expression and matrix deposition by fibroblasts in vitro. TSP1 stimulation of collagen was inhibited by a peptide that blocks TSP1 binding to calreticulin, demonstrating the requirement for cell surface calreticulin. Collagen stimulation was independent of TGF-β activity and Smad phosphorylation but was blocked by an Akt inhibitor, suggesting that signaling through the Akt pathway is important for regulation of collagen through TSP1 binding to calreticulin. These studies identify a novel function for the NTD of TSP1 as a mediator of collagen expression and deposition during tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724603      PMCID: PMC2947268          DOI: 10.2353/ajpath.2010.090903

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Preparation and analysis of synthetic multicomponent extracellular matrix.

Authors:  Kim S Midwood; Iwona Wierzbicka-Patynowski; Jean E Schwarzbauer
Journal:  Methods Cell Biol       Date:  2002       Impact factor: 1.441

2.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.

Authors:  M L Iruela-Arispe; P Bornstein; H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.

Authors:  S Schultz-Cherry; J Lawler; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

4.  Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.

Authors:  L Zhou; J S Isenberg; Z Cao; D D Roberts
Journal:  Oncogene       Date:  2006-01-26       Impact factor: 9.867

5.  Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin.

Authors:  S Goicoechea; A W Orr; M A Pallero; P Eggleton; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.

Authors:  Silvia Goicoechea; Manuel Antonio Pallero; Paul Eggleton; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

7.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1.

Authors:  M J Reed; L Iruela-Arispe; E R O'Brien; T Truong; T LaBell; P Bornstein; E H Sage
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

8.  Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

9.  A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1.

Authors:  J C Adams; N Kureishy; A L Taylor
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  14 in total

1.  Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1.

Authors:  Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster
Journal:  Circulation       Date:  2017-08-04       Impact factor: 29.690

Review 2.  Matricellular proteins and biomaterials.

Authors:  Aaron H Morris; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2014-03-20       Impact factor: 11.583

Review 3.  The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease.

Authors:  Benjamin Y Owusu; Kurt A Zimmerman; Joanne E Murphy-Ullrich
Journal:  J Cell Commun Signal       Date:  2017-10-28       Impact factor: 5.782

Review 4.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

5.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 6.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

7.  Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.

Authors:  John C Schmitz; Petr Protiva; Arijeet K Gattu; Teruo Utsumi; Yasuko Iwakiri; Antonio G Neto; Margo Quinn; Mona L Cornwell; Philip Fitchev; Aurelia Lugea; Susan E Crawford; Chuhan Chung
Journal:  Am J Pathol       Date:  2011-09-28       Impact factor: 4.307

8.  Molecular and structural insight into the role of key residues of thrombospondin-1 and calreticulin in thrombospondin-1-calreticulin binding.

Authors:  Qi Yan; Joanne E Murphy-Ullrich; Yuhua Song
Journal:  Biochemistry       Date:  2011-01-04       Impact factor: 3.162

9.  Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.

Authors:  Alessandro Prete; Agnes S Lo; Peter M Sadow; Swati S Bhasin; Zeus A Antonello; Danica M Vodopivec; Soumya Ullas; Jennifer N Sims; John Clohessy; Ann M Dvorak; Tracey Sciuto; Manoj Bhasin; Joanne E Murphy-Ullrich; Jack Lawler; S Ananth Karumanchi; Carmelo Nucera
Journal:  Clin Cancer Res       Date:  2018-08-03       Impact factor: 12.531

10.  Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acids.

Authors:  Brian S Finlin; Beibei Zhu; Catherine P Starnes; Robert E McGehee; Charlotte A Peterson; Philip A Kern
Journal:  J Nutr Biochem       Date:  2013-03-22       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.